The first drug of this type to be manufactured will be Aminor, followed by Trienor, Estracip and Etinor, according to Granma daily.
At present, the facility, owned by MedSol Laboratories , is in the testing phase of the water and climate system, as well as in the completion of the floor and adjustment of the technological equipment.
Oral contraceptives were affected throughout the year, due to the fact that the plant had to be shut down for the investment process, and since they are hormones, there was no way to transfer their production to other facilities, the daily reported.
Recently, Cuba reported that it would resume production of drugs used in the therapeutic treatment of patients with cancer and other invasive diseases.
Some of them are paclitaxel 300 mg/bulb, Methotrexate 50 mg/bulb, Fluorouracil 500 mg/bulb.
In August, the availability of 13 products was guaranteed and they were distributed, as usual, to the hospitals that provide treatment with this therapy.